D'Cruz AK, Vaish R. Risk-based oral cancer screening - lessons to be learnt. Nat Rev Clin Oncol 2021;18(8):471–472. DOI: 10.1038/s41571-021-00511-2
Seenan P, Conway D. Smokeless tobacco - a substantial risk for oral potentially malignant disorders in South Asia. Evid Based Dent. 2017;18(2):54-55. DOI: 10.1038/sj.ebd.6401242. PMID: 28642557.
Ogden GR, Macluskey M. An overview of the prevention of oral cancer and diagnostic markers of malignant change: 1. Prevention. Dent Update 2000;27(2):95–99. DOI: 10.12968/denu.2000.27.2.95. PMID: 11218278.
D'souza S, Addepalli V. Preventive measures in oral cancer: an overview. Biomed Pharmacother 2018;107:72-80. DOI: 10.1016/j.biopha.2018.07.114. Epub 2018. PMID: 30081204.
Lippman SM, Sudbø J, Hong WK. Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 2005;23(2):346–356. DOI: 10.1200/JCO.2005.09.128
Meyskens FL Jr, Mukhtar H, Rock CL, et al. Cancer prevention: obstacles, challenges and the road ahead J Natl Cancer Inst 2015;108(2):djv309. DOI: 10.1093/jnci/djv309. PMID: 26547931; PMCID: PMC4907357.
Schüz J, Espina C, Wild CP. Primary prevention: a need for concerted action. Mol Oncol 2019;13(3):567–578. DOI: 10.1002/1878-0261.12432. Epub 2019. PMID: 30582778 PMCID: PMC6396360.
Foy JP, Bertolus C, William WN Jr, et al. Oral premalignancy: the roles of early detection and chemoprevention. Otolaryngol Clin North Am 2013;46(4):579–597. DOI: 10.1016/j.otc.2013.04.010. Epub 2013. PMID: 23910471; PMCID: PMC3734384.
Neetha MC, Panchaksharappa MG, Pattabhiramasastry S, et al. Chemopreventive synergism between green tea extract and curcumin in patients with potentially malignant oorders: a double-blind, randomized preliminary study. Contemp Dent Pract 2020;21(5):521–531. DOI: 10.5005/jp-journals-10024-2823. PMID: 32690834.
Dunn BK, Greenwald P. Cancer prevention I: introduction. Semin Oncol 2010;37(3):190–201. DOI: 10.1053/j.seminoncol.2010.06.011. PMID: 20709204.
Maresso KC, Tsai KY, Brown PH, et al. Molecular cancer prevention: current status and future directions. CA Cancer J Clin 2015;65(5):345–383. DOI: 10.3322/caac.21287. Epub 2015. PMID: 26284997; PMCID: PMC4820069.
Miao L, Zhang Y, Huang L. mRNA vaccine for cancer immunotherapy. Mol Cancer 2021;20(1):41. DOI: 10.1186/s12943-021-01335-5. PMID: 33632261; PMCID: PMC7905014.